MergerLinks Header Logo

Announced

Completed

Tribe Capital and Natural Capital led a $50m Series B round in Ashvattha Therapeutics.

Synopsis

Tribe Capital and Natural Capital, a venture capital firms, led a $50m Series B round in Ashvattha Therapeutics, a biotechnology company.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite